Catalyst Pharmaceuticals (CPRX) Other Non-Current Liabilities (2010 - 2026)

Catalyst Pharmaceuticals (CPRX) has 15 years of Other Non-Current Liabilities data on file, last reported at $280000.0 in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 8.11% year-over-year to $280000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $280000.0 (up 8.11% YoY) and the FY2025 annual result came in at $209000.0, down 33.65% from the prior year.
• Other Non-Current Liabilities grew to $280000.0 in Q1 2026, from $209000.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $14.7 million in Q3 2022 to a low of $161000.0 in Q3 2025.
• A 5-year average of $4.7 million and a median of $2.6 million in 2024 frame the typical range for Other Non-Current Liabilities.
• Annual changes were most pronounced in 2025 — Other Non-Current Liabilities plunged 94.22% — and 2026, when it advanced 8.11%.
• Tracing CPRX's Other Non-Current Liabilities over 5 years: stood at $14.1 million in 2022, then slumped by 78.8% to $3.0 million in 2023, then sank by 89.44% to $315000.0 in 2024, then slumped by 33.65% to $209000.0 in 2025, then jumped by 33.97% to $280000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $280000.0 (Q1 2026), $209000.0 (Q4 2025), and $161000.0 (Q3 2025), per Business Quant data.